During the past decade, Detroit Clinical Research Center conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 12 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Detroit Clinical Research Center" #1 sponsor was "Celgene" with 2 trials, followed by "Curemark" with 2 trials sponsored, "DEKK-TEC, Inc." with 2 trials sponsored, "Hennepin Healthcare Research Institute" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Detroit Clinical Research Center" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Bayer" with 2 trials as a collaborator, "Berman Center for Outcomes and Clinical Research" with 2 trials as a collaborator, "Monash University" with 2 trials as a collaborator and "National Health and Medical Research Council, Australia" with 2 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Detroit Clinical Research Center" are "Breast Cancer" (3 trials), "Advanced Cancer" (2 trials), "Autism" (2 trials), "Cancer" (2 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "Detroit Clinical Research Center" in a lesser frequency.

Most popular intervention types in "Detroit Clinical Research Center" are "Drug" (29 trials), "Device" (6 trials), "Other" (5 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "4-Demethyl-4-cholesteryloxycarbonylpenclomedine" (2 trials), "CM-AT" (2 trials), "Fulvestrant" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Detroit Clinical Research Center" are 37 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Detroit Clinical Research Center". undefined are not yet recruiting, 4 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Detroit Clinical Research Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Detroit Clinical Research Center, 6 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".